Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

NCT05281614 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Etanercept
DRUG: Vedolizumab

Sponsor

Benaroya Research Institute

Collaborators

[object Object]